カテゴリ： GlobalData, アメリカ, 企業調査

Quest Diagnostics Inc (DGX)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Quest Diagnostics Inc (DGX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011053
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月21日
◆ページ数：124
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology. It also provides diagnostic products. The company offers these services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. The company is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Quest Diagnostics Inc, Medical Equipment, Deal Details 15
Asset Purchase 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 15
Venture Financing 16
Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 16
Partnerships 17
Vermillion Enters into Licensing Agreement with Quest Diagnostics 17
Clinical Genomics Enters into Licensing Agreement with CSIRO 18
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 19
Illumina Enters Into Licensing Agreement With Quest Diagnostics 20
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 21
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 22
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 23
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 24
Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 25
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 26
Biocept to Form Partnership with Quest Diagnostics Mexico 27
DermTech Enters into Agreement with Dermpath Diagnostics 28
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 29
Genomic Vision Extends Agreement with Quest Diagnostics 30
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 31
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 32
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 33
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 34
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 35
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 36
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 37
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn’s Disease 38
Vermillion Signs Agreement With Quest Diagnostics 39
Debt Offering 40
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 40
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 49
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 51
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 52
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 53
Asset Transactions 54
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 54
Acquisition 56
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 57
Quest Diagnostics May Sell itself 59
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 60
Clinical Genomics Acquires Enterix From Quest Diagnostics 61
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 62
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 64
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 65
Solstas Lab Partners Acquires NextWave Diagnostic Labs 66
Solstas Lab Partners Acquires Wilmington Pathology Lab 67
Solstas Lab Partners Acquires Select Diagnostics 68
Quest Diagnostics Completes Acquisition Of Celera 69
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 71
Quest Diagnostics Inc – Key Competitors 73
Quest Diagnostics Inc – Key Employees 74
Quest Diagnostics Inc – Locations And Subsidiaries 76
Head Office 76
Other Locations & Subsidiaries 76
Joint Venture 78
Recent Developments 80
Strategy And Business Planning 80
Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services 80
Financial Announcements 81
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 81
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 82
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 83
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 84
Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 85
Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 86
Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 88
Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 90
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 91
Corporate Communications 92
Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 92
Legal and Regulatory 93
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system 93
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 94
Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation 95
Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation 96
Aug 18, 2016: Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services 97
Government and Public Interest 98
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 98
Product News 99
Jul 19, 2017: Quest Diagnostics Launches QHerit, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines 99
Jun 01, 2016: One Year After Launch, BRCA Share Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk 101
May 26, 2016: Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk 103
Apr 15, 2016: New Diagnostic Pathways Could Improve Dementia Diagnosis, According to Consensus Statements to Be Presented at the American Academy of Neurology Annual Meeting 105
Apr 14, 2016: Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies 107
Feb 24, 2016: Quest Diagnostics and Inovalon Bring Real-Time, Point-of-Care Analytics to HIMSS16 with Data Diagnostics 108
Feb 22, 2016: Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum Brand 110
Other Significant Developments 112
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 112
Sep 26, 2017: Rx Savings Solutions Helps Quest Diagnostics’ Health Plan Members Save Money On Prescription Drugs 113
Sep 07, 2017: Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions 114
Aug 30, 2017: MDI Solutions selected to provide Cloverleaf Secure Courier implementation and training services 116
Jan 18, 2017: Quest Diagnostics Launches Nation’s First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy 117
Nov 21, 2016: Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri 118
Sep 13, 2016: Optum and Quest Diagnostics Partner to Help Make the Health System Work Better for Patients, Physicians, Health Plans and Employers 119
Aug 03, 2016: Quest Diagnostics and AncestryDNA Collaborate to Expand Consumer DNA Testing 120
Jul 13, 2016: Apollo Enters Agreement with ChartMaxx from Quest Diagnostics to Provide Enterprise Imaging and Content Management Technology 121
Jun 15, 2016: Quest Diagnostics and Safeway Team to Offer Convenient Diagnostic Testing to Customers in More States 122
May 31, 2016: Quest Diagnostics and HCA’s HealthONE System Partner to Deliver High-Value and Innovative Laboratory Services at Six Denver-Area HealthONE Hospitals 123
Appendix 124
Methodology 124
About GlobalData 124
Contact Us 124
Disclaimer 124

List of Tables
Quest Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Quest Diagnostics Inc, Deals By Market, 2011 to YTD 2017 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Quest Diagnostics Acquires Assets from California Laboratory Associates 15
Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 16
Vermillion Enters into Licensing Agreement with Quest Diagnostics 17
Clinical Genomics Enters into Licensing Agreement with CSIRO 18
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 19
Illumina Enters Into Licensing Agreement With Quest Diagnostics 20
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 21
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 22
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 23
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 24
Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 25
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 26
Biocept to Form Partnership with Quest Diagnostics Mexico 27
DermTech Enters into Agreement with Dermpath Diagnostics 28
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 29
Genomic Vision Extends Agreement with Quest Diagnostics 30
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 31
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 32
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 33
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 34
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 35
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 36
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 37
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 38
Vermillion Signs Agreement With Quest Diagnostics 39
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 40
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 49
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 51
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 52
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 53
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 54
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 57
Quest Diagnostics May Sell itself 59
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 60
Clinical Genomics Acquires Enterix From Quest Diagnostics 61
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 62
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 64
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 65
Solstas Lab Partners Acquires NextWave Diagnostic Labs 66
Solstas Lab Partners Acquires Wilmington Pathology Lab 67
Solstas Lab Partners Acquires Select Diagnostics 68
Quest Diagnostics Completes Acquisition Of Celera 69
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 71
Quest Diagnostics Inc, Key Competitors 73
Quest Diagnostics Inc, Key Employees 74
Quest Diagnostics Inc, Subsidiaries 76
Quest Diagnostics Inc, Joint Venture 78

★海外企業調査レポート[Quest Diagnostics Inc (DGX)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Centric Health Corp (CHH)：製薬・医療：M&Aディール及び事業提携情報
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • Sidi Kerir Petrochemicals Co (SKPC)：企業の財務・戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co (Sidpec), a subsidiary of Egyptian Petrochemicals Holding Co, is a chemical company that manufactures and distributes petrochemical products. The company offers high density polyethylene and linear low density polyethylene which are used in plastic applications i …
  • Superior Industries International, Inc.：企業の戦略・SWOT・財務分析
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • GI Dynamics Inc (GID)：医療機器：M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • Hovid Berhad (HOVID)：企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DCP Midstream LP (DCP)：企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • UniQure NV (QURE)：製薬・医療：M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)：医療機器：M&Aディール及び事業提携情報
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • Orkuveita Reykjavikur-エネルギー分野：企業M&A・提携分析
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • Monogram Biosciences Inc：企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Enerchem International Inc：企業の戦略的SWOT分析
    Enerchem International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Baoding Lightway Green Energy Technology Co Ltd：企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Schneider Electric SE：企業の戦略・SWOT・財務分析
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Greatcell Solar Ltd (GSL)：企業の財務・戦略的SWOT分析
    Greatcell Solar Ltd (GSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Global Cardiovascular Innovation Center：医療機器：M&Aディール及び事業提携情報
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Amatsigroup SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary Amatsigroup SAS (Amatsigroup) is a contract development manufacturing organization that offers human and veterinary pharmaceutical development through preclinical and clinical phases. The organization provides services such as bioservices, clinical trial supply, formulation development and m …
  • Vornado Realty Trust：企業の戦略・SWOT・財務分析
    Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report Summary Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mitsui E&S Holdings Co., Ltd. (7003)：企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Solaris Oilfield Infrastructure Inc (SOI)：石油・ガス：M&Aディール及び事業提携情報
    Summary Solaris Oilfield Infrastructure Inc (Solaris) is a provider of supply chain management and logistics solutions for oil and natural gas industry. The company manufactures and provides mobile proppant management systems that unload, store and deliver proppant at oil and natural gas well sites …
  • BiosanaPharma BV：製薬・医療：M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆